Sun Pharma Laboratories is a finished-dose manufacturer based in India. It appears in 88 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with CDSCO (India) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil) and NAFDAC (NG). Customs aggregates show $523K of exports covering 2 molecules to 1 destination in 2025.
| Site | FDA FEI |
|---|---|
| JAMMU, India | Not on file |
| Jammu, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 59 | None |
| ARCSA (EC) | 29 | None |
| ANVISA (Brazil) | None | 1 |
| NAFDAC (NG) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $523K | 1 |
| 2023 | Not reported | $101K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Sun Pharma Laboratories comes back tiered against every other supplier able to file there.
Start for free